Inpatient & Outpatient Clinical Trial Sites
hVIVO owns a network of specialist inpatient and outpatient clinical trial sites across the UK and EU, purpose‑built for early‑phase infectious disease studies, respiratory, cardiometabolic, dermatology, and sleep studies. Facilities include a 50‑bed quarantine unit in London, 150+ beds across three clinical pharmacology sites in Germany, integrated laboratory capabilities, and large‑scale screening throughout.
- 150+ inpatient beds across 3 sites in the UK & EU
- Resourced by expert teams 24/7, fully trained to GCP, GLP requirements with on site trainer
- 4 outpatient units in the UK & Germany with integrated lab processing
- 50‑bed quarantine facility (London) co‑located with specialty laboratory for infectious disease and respiratory conditions
- 3 sites in Germany with strong links to university hospitals for special populations and patient populations in cardiometabolic, renal and hepatic impairment, dermatology and women’s health
- Capacity to screen 1,000+ participants per week; 400,000+ participant database – delivered by dedicated recruitment team
UK - London
In-patient features:
-
50‑bed quarantine unit
-
HEPA‑filtered negative‑pressure rooms
-
BSL‑3 capability - with hVIVO Laboratories
-
On‑site pharmacy
-
Pneumatic tube systems
-
14 bed outpatient unit on the same floor
-
Infectious disease and Respiratory focus
Germany - Mannheim
Inpatient features:
- 94 beds (58 long‑term)
- Three wards and large outpatient facility
- Study types include, First-in-Human, QTc, narcotics/opioids, DDI/FDI, BE/BA
- On-site pharmacy
- Cardiometabolic focus
Germany - Kiel
Inpatient features:
- 26 beds (20 high‑care)
- Dedicated to renal/hepatic impairment and elderly populations
- Continuous monitoring
- On‑site pharmacy and lab processing
Germany - Berlin
Inpatient features:
- 26 beds (18 intensive monitoring)
- Specialised in women’s health
Out-Patient
Out-patient UK & Germany: 4 units with integrated lab or processing facilities; on‑site IMP rooms; safety labs (blood/urine, vitals, ECG), medical review and exams
Reasons to Consider hVIVO Sites
-
Scale + speed – Over 150 inpatient beds and 4 outpatient units with integrated labs enable rapid start‑up and high‑throughput execution.
-
Purpose‑built for infectious disease & early phase studies in cardio-metabolic, women's health and respiratory.
-
World‑class quarantine infrastructure (BSL‑3 capable) and specialist respiratory/challenge testing in outpatient clinics.
-
Seamless lab connectivity integrated laboratory or processing across the network accelerates sample flow and data.